Nautilus Biotechnology is based in Seattle. It has raised $445M in total funding. Latest round: IPO.
Nautilus Biotechnology is based in Seattle. Nautilus Biotechnology has raised $445M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in July 2021. The round record for Nautilus Biotechnology runs through 2021; nothing later has been disclosed. Investors on record include Andreessen Horowitz, Madrona Venture Group, AME Cloud Ventures, Vulcan Capital, Perceptive Advisors, Bezos Expeditions and 2 others. 8 distinct backers are named across the disclosed rounds.
Every Nautilus Biotechnology figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Seattle at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026